###begin article-title 0
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DC-SIGN on B Lymphocytes Is Required For Transmission of HIV-1 to T Lymphocytes
###end article-title 0
###begin p 1
currency Current address: School of Health Sciences, Eastern Michigan University, Ypsilanti, Michigan, United States of America
###end p 1
###begin p 2
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 561 566 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 729 734 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 806 811 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 859 864 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 960 965 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infection of T cells by HIV-1 can occur through binding of virus to dendritic cell (DC)-specific ICAM-3 grabbing nonintegrin (DC-SIGN) on dendritic cells and transfer of virus to CD4+ T cells. Here we show that a subset of B cells in the blood and tonsils of normal donors expressed DC-SIGN, and that this increased after stimulation in vitro with interleukin 4 and CD40 ligand, with enhanced expression of activation and co-stimulatory molecules CD23, CD58, CD80, and CD86, and CD22. The activated B cells captured and internalized X4 and R5 tropic strains of HIV-1, and mediated trans infection of T cells. Pretreatment of the B cells with anti-DC-SIGN monoclonal antibody blocked trans infection of T cells by both strains of HIV-1. These results indicate that DC-SIGN serves as a portal on B cells for HIV-1 infection of T cells in trans. Transmission of HIV-1 from B cells to T cells through this DC-SIGN pathway could be important in the pathogenesis of HIV-1 infection.
###end p 2
###begin title 3
Synopsis
###end title 3
###begin p 4
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 55 65 <span type="species:ncbi:11676">AIDS virus</span>
###xml 67 97 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
###xml 99 104 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 127 132 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 464 469 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 519 524 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 634 639 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A cell surface molecule, DC-SIGN, is known to bind the AIDS virus, human immunodeficiency virus 1 (HIV-1), on dendritic cells. HIV-1 can then be transferred from these dendritic cells to CD4+ T cells, in which the virus replicates and kills the T cells. Here, Rappocciolo and colleagues present their findings that DC-SIGN serves a similar function on a subset of B cells of the peripheral blood and tonsils. Although B cells that express DC-SIGN do not replicate HIV-1, they serve as portals for transfer and enhanced HIV-1 infection of CD4+ T cells, the major site of virus replication in the host. This newly described pathway for HIV-1 infection of T cells via B cells could be important in the pathogenesis of the virus infection.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b001">1</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b002">2</xref>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b003">3</xref>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 540 545 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 can bind to the type II C-type lectin receptor, dendritic cell (DC)-specific ICAM-3 grabbing nonintegrin (DC-SIGN; CD209), on myeloid DC and be transferred to CD4+ T cells [1,2]. An important feature of this trans pathway is that the virus does not establish an efficient, productive infection in these DC. Rather, it is captured by the DC and internalized in distinct intracellular compartments, and then transmitted to CD4+ T cells wherein it undergoes productive replication [3]. This is considered to be an alternative pathway to HIV-1 cis infection of T cells, macrophages, and DC that occurs through binding to the primary CD4 receptor and either of the chemokine coreceptors CXCR4 or CCR5.
###end p 6
###begin p 7
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b004">4</xref>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b005">5</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b006">6</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b010">10</xref>
###xml 759 762 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b011">11</xref>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 331 336 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 346 353 <span type="species:ncbi:9606">persons</span>
###xml 534 539 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 694 699 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
B lymphocytes have also been implicated in trans infection of T cells with HIV-1 [4]. Given the intimate association of B cells and T cells in lymphoid tissue, B cell-mediated trans infection pathways could be important in the spread of virus to T cells. B cells derived either from lymphoid tissue or from the peripheral blood of HIV-1-infected persons carry replication-competent virus of either the CXCR4 (X4) or CCR5 (R5) tropic strain [5]. The mechanism by which B cells have been shown to transmit the virus involves binding of HIV-1 immune complexes to CR2 or CD21 on the surface of B cells and subsequent passage to the T cells [6-10]. Other reports have proposed a role for B cells in HIV-1 infection involving B cell activation processes induced by nef-expressing macrophages [11].
###end p 7
###begin p 8
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b012">12</xref>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b015">15</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b016">16</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b017">17</xref>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 610 611 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 125 130 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 224 229 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 320 325 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 435 440 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
B cells express some C-type lectin receptors [12-15], with conflicting reports on expression of DC-SIGN [16,17]. Transfer of HIV-1 by B cells via a C-type lectin receptor pathway described for DC could be of significance in HIV-1 pathogenesis. We therefore investigated B cells for a DC-SIGN-mediated, trans pathway for HIV-1 infection of CD4+ T cells. We found that a subset of B cells in the peripheral blood and tonsils of healthy, HIV-1 seronegative donors expressed DC-SIGN, and that DC-SIGN expression increased after stimulation with interleukin 4 (IL-4) and CD40 ligand (CD40L). The stimulated, DC-SIGN+ B cells mediated trans infection of T cells.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
DC-SIGN Expression in B cells and Enhancement by Stimulation with IL-4 and CD40L
###end title 10
###begin p 11
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 284 292 284 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 625 626 621 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 660 668 656 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 695 703 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 236 241 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 251 258 <span type="species:ncbi:9606">persons</span>
Our initial, three-color flow cytometric analysis of peripheral blood mononuclear cells (PBMC) showed that DC-SIGN was expressed on a small but distinct subset of CD19+ B cells within the CD45+/CD19+ gated population of PBMC of normal, HIV-1-negative persons (representative example, Figure 1A). To extend this finding, we analyzed DC-SIGN expression on B cells that were purified from PBMC of 33 normal donors by sorting with anti-CD19 monoclonal antibody (mAb)-coated magnetic beads. Flow cytometric results showed that DC-SIGN was expressed on 7.9 +/- 1.8% (mean +/- standard error [SE]) of purified, peripheral blood CD20+ B cells (representative example, Figure 1B, T0; cumulative results, Figure 1C, T0).
###end p 11
###begin p 12
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b015">15</xref>
###xml 452 461 450 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020070-sg001">Figure S1</xref>
###xml 491 492 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 752 753 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 881 882 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 925 927 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b018">18</xref>
###xml 928 930 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b019">19</xref>
###xml 1020 1022 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b020">20</xref>
###xml 1050 1052 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b021">21</xref>
###xml 1080 1082 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b022">22</xref>
###xml 1266 1274 1264 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 1282 1291 1280 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020070-sg001">Figure S1</xref>
###xml 1642 1650 1639 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 1683 1692 1680 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020070-sg001">Figure S1</xref>
###xml 443 450 <span type="species:ncbi:9606">persons</span>
We next addressed whether expression of DC-SIGN on this subset of B cells was related to a state of cellular activation. For this, we determined the proportion of B cells that expressed CD23, another type II C-type lectin receptor that is a low-affinity Fc receptor for IgE (Fc epsilon RII) and is associated with B cell activation and differentiation [15]. We found that DC-SIGN and CD23 were coexpressed on 8.1 +/- 1.7% of B cells in normal persons (Figure S1A, T0). Indeed, 80% of DC-SIGN+ B cells also expressed CD23 (unpublished data). To further delineate the relationship of B cell activation to DC-SIGN, we examined whether stimulation of B cells with the T helper type 2 (Th2) cytokine interleukin 4 (IL-4) alone or in combination with the CD4+ T cell activation factor CD40L could alter expression of DC-SIGN and CD23, a procedure that mimics activation of B cells by CD4+ T helper cells during antigen processing [18,19]. Also, IL-4 has been shown to up-regulate expression of DC-SIGN on monocyte-derived DC [20], breast-milk macrophages [21], and the THP-1 cell line [22]. Our data demonstrate that treatment of purified B cells with a range of concentrations of either IL-4 or CD40L alone had little effect on the expression of DC-SIGN or CD23 by 24 h (Figure 1D, top; Figure S1B, top) or 48 h (unpublished data). In contrast, treatment with a combination of different concentrations of IL-4 and CD40L had a synergistic effect on expression of DC-SIGN and CD23 on B cells, with the greatest increase in the number of B cells expressing DC-SIGN being induced by stimulation with 1,000 U/ml of IL-4 and 1 mug/ml of CD40L for 24 h (Figure 1D, top and bottom, respectively; Figure S1B, bottom). This treatment was therefore used for stimulation of B cells in subsequent experiments.
###end p 12
###begin p 13
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 288 289 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 301 309 297 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 458 459 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 481 482 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 487 488 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 573 574 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 581 582 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 593 602 581 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020070-sg001">Figure S1</xref>
###xml 630 631 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Cumulative data from 33 normal donors showed that expression of DC-SIGN by purified, peripheral blood CD20+ B cells significantly increased after stimulation of the cells for 24 h with IL-4 and CD40L (representative example, Figure 1B) from a mean level of 7.9 +/- 1.8% to 28.2 +/- 3.3% (p = 0.0001) (Figure 1C). Moreover, the mean fluorescence intensity (MFI) of DC-SIGN on the B cells increased 3-fold after stimulation, from 10.8 +/- 2.4 to 30.2 +/- 6.6 (p < 0.005). The DC-SIGN+ CD23+ B cell population also increased from 8.1 +/- 1.7% at 0 h to 25.7 +/- 3.2% at 24 h (n = 33; p < 0.0002; Figure S1A, T24), with 86% of DC-SIGN+ cells expressing CD23 after 24 h of stimulation (unpublished data).
###end p 13
###begin p 14
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b023">23</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b024">24</xref>
###xml 450 457 450 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0020070-t001">Table 1</xref>
To confirm the increase in DC-SIGN expression in B lymphocytes stimulated by IL-4 and CD40L, we measured the level of DC-SIGN mRNA by real-time reverse transcriptase PCR [23,24] in B cells stimulated with IL-4 and CD40L compared to unstimulated B cells. B cells from five of seven normal donors (donors 1, 2, 4, 5, and 7) had large, 6.1- to 122.4-fold increases in levels of DC-SIGN mRNA, accompanied by an increase in surface expression of DC-SIGN (Table 1). B lymphocytes from the other two donors (donors 3 and 6) had low-to-moderate, 1.1- to 2.1-fold increases in DC-SIGN mRNA levels together with increases in surface expression of DC-SIGN after stimulation.
###end p 14
###begin p 15
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 469 477 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g001">Figure 1</xref>
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 117 122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 139 <span type="species:ncbi:9606">persons</span>
###xml 287 292 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 302 309 <span type="species:ncbi:9606">persons</span>
###xml 323 328 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 460 467 <span type="species:ncbi:9606">persons</span>
###xml 549 554 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 684 689 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 701 708 <span type="species:ncbi:9606">persons</span>
###xml 724 729 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next examined whether HIV-1 infection altered the number of B cells expressing DC-SIGN in the peripheral blood of HIV-1-infected persons, and the capacity of their B cells to respond to stimulation with IL-4 and CD40L. We found that the percentage of DC-SIGN+ B cells in the blood of HIV-1-infected persons with chronic HIV-1 infection who were antiretroviral therapy (ART) naive or those who had suppressed viral infection on ART was similar to uninfected persons (Figure 1C). However, expression of DC-SIGN was not enhanced on B cells from the HIV-1-infected subjects on ART in response to stimulation with IL-4 and CD40L, whereas DC-SIGN expression was enhanced in B cells from HIV-1-uninfected persons and ART-naive, HIV-1-infected subjects.
###end p 15
###begin p 16
###xml 531 532 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 554 562 554 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g002">Figure 2</xref>
###xml 601 602 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Next we compared the level of expression of DC-SIGN to other surface molecules that are known to increase during B cell activation and that play an important role in the interaction between B and T lymphocytes. Flow cytometry analysis of purified, IL-4- and CD40L-stimulated B cells for expression of DC-SIGN, CD23, the B cell signal transduction molecule CD22, and T cell co-stimulatory molecules CD58, CD80, and CD86 showed that there was an increase in coexpression of all of these markers with DC-SIGN at 24 h compared to 0 h (p < 0.005; T0 and T24, Figure 2A) or mock-stimulated B cells at 24 h (p < 0.05; unpublished data).
###end p 16
###begin p 17
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g002">Figure 2</xref>
###xml 159 164 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 445 450 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Finally, we determined the expression of CD4 and the chemokine receptors CXCR4 and CCR5 on B cells, which are the primary receptor and coreceptors involved in HIV-1 cis infection. Although a small subset of B cells from the blood expressed low levels of CD4, this marker was not detectable after 24 h (Figure 2B) or 48 h (unpublished data) of stimulation of the B cells with IL-4 and CD40L. High levels of expression of the CXCR4 coreceptor for HIV-1 were evident on most B cells before and after stimulation with IL-4 and CD40L, whereas the CCR5 coreceptor was not expressed.
###end p 17
###begin p 18
###xml 274 279 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 302 307 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 317 324 <span type="species:ncbi:9606">persons</span>
###xml 363 368 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 378 385 <span type="species:ncbi:9606">persons</span>
###xml 507 512 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Taken together, these results indicate that a distinct population of activated B lymphocytes constitutively expressed DC-SIGN in the blood of normal donors. Moreover, there was a significant increase in the frequency and intensity of DC-SIGN-expressing B cells derived from HIV-1-negative subjects and HIV-1-infected persons not on ART, which was not observed in HIV-1-infected persons on ART, after 24 h of stimulation with IL-4 and CD40L. Finally, the activated B cells expressed the CXCR4 coreceptor for HIV-1, but not the primary CD4 receptor or the CCR5 coreceptor for the virus.
###end p 18
###begin title 19
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
B Cells Express Sufficient Levels of DC-SIGN for HIV-1 trans Infection of T Cells
###end title 19
###begin p 20
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b025">25</xref>
###xml 516 517 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 590 591 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 626 627 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 682 683 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 690 698 682 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g003">Figure 3</xref>
###xml 790 798 782 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g003">Figure 3</xref>
###xml 922 930 914 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g003">Figure 3</xref>
###xml 171 176 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1059 1064 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
It has been shown in both DC and transfected cell lines that surface expression of a minimum of approximately 60,000 molecules of DC-SIGN is necessary for transmission of HIV-1 to T cells [25]. We therefore determined the level of expression of DC-SIGN on blood-derived B cells as compared to DC and Raji-DC-SIGN cells by antibody binding capacity (ABC) and the number of molecules of equivalent soluble fluorochrome (MESF). The results show that IL-4- and CD40L-stimulated B cells expressed 137,870 +/- 22,432 ABC (n = 6) for DC-SIGN compared to mock-stimulated B cells (36,946 +/- 1,125, n = 6), DC (213,350 +/- 43,370 ABC; n = 6), and Raji-DC-SIGN cells (225,750 +/- 19,880 ABC; n = 4) (Figure 3A). A similar quantitative expression of DC-SIGN was observed on activated B cells by MESF (Figure 3B). The MESF and ABC histogram profiles for DC-SIGN on activated B cells compared to DC and Raji-DC-SIGN cells are shown in Figure 3C. These data support that IL-4- and CD40L-stimulated B cells expressed a sufficient number of DC-SIGN molecules for transfer of HIV-1 to T cells.
###end p 20
###begin title 21
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activated B Cells Transmit HIV-1 X4 and R5 Strains to T Lymphocytes
###end title 21
###begin p 22
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b001">1</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b026">26</xref>
###xml 389 391 389 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 429 430 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b001">1</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b027">27</xref>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 643 651 643 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g004">Figure 4</xref>
###xml 797 798 797 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 891 892 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 930 931 930 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1253 1261 1253 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g004">Figure 4</xref>
###xml 1359 1362 1359 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1528 1529 1528 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 113 118 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 231 236 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 346 351 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 506 511 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 737 742 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1015 1020 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1090 1095 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1136 1141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1402 1407 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1419 1424 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1772 1777 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our finding that B lymphocytes expressed DC-SIGN led us to investigate whether these cells could be exploited by HIV-1 as a means for enhanced infection of T cells, as has been demonstrated for DC [1,26]. We first examined whether HIV-1 was able to bind to B cells and be transmitted to T lymphocytes through DC-SIGN using a low concentration of HIV-1 (multiplicity of infection [MOI] = 10-4, corresponding to 10 pg of p24 per 106 cells), similar to that used in studies of DC-SIGN-related transmission of HIV-1 from DC to T cells [1,27]. This low amount of virus usually does not result in efficient cis infection of T cells. As displayed in Figure 4A, when the purified IL-4- and CD40L-stimulated B cells were incubated with X4 tropic HIV-1 (strain IIIb) and then co-cultured with autologous CD4+ T cells, virus replicated in the cultures as shown by an increase from undetectable, <1 x 101 pg of p24 per ml at day 4, to >4 x 103 pg at day 16. Purified B cells not stimulated with IL-4 and CD40L, and loaded with HIV-1 X4 and cultured with T cells for 24 h, were not capable of enhancing HIV-1 infection in the co-cultures. Levels of HIV-1 X4 remained below detection in IL-4- and CD40L-stimulated B cells, mock-stimulated B cells, and T cells alone (Figure 4A). This indicates that virus replication in the B-T cell co-cultures was not a result of direct, cis infection of the T cells or B cells by HIV-1. For these HIV-1 transmission experiments, we used B cells obtained from magnetic bead-purified fractions with >96% CD20+ cells and <1% T cells and monocytes. However, to ensure that the observed results were not due to contamination with other cell types, we also found that fractions of >96% pure B cells obtained by flow cytometry sorting were able to transmit HIV-1 to T cells with the same efficiency as the magnetic bead-purified B cells (unpublished data).
###end p 22
###begin p 23
###xml 211 219 211 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g004">Figure 4</xref>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 313 314 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 376 378 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 394 395 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 407 408 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 435 437 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 444 446 442 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 556 564 554 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g004">Figure 4</xref>
###xml 118 123 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 233 238 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Further experiments demonstrated that IL-4- and CD40L-activated B cells loaded with three different concentrations of HIV-1 X4 resulted in a dose response-related level of infection in the B-T cell co-cultures (Figure 4B). Levels of HIV-1 p24 increased from undetectable, <1 x 101 pg per ml on day 4, to >/=5 x 104 pg of p24 per ml on day 16 at the highest input MOI (i.e., 10-3), and >1.7 x 104 and >8 x 103 pg per ml at the lower, 10-4 and 10-5 MOI, respectively. Virus did not replicate at any of these input concentrations in B cells or T cells alone (Figure 4B).
###end p 23
###begin p 24
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g002">Figure 2</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b028">28</xref>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g002">Figure 2</xref>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g004">Figure 4</xref>
###xml 580 588 580 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g002">Figure 2</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b028">28</xref>
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 692 700 692 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g004">Figure 4</xref>
###xml 716 724 716 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g004">Figure 4</xref>
###xml 473 478 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 529 534 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 732 737 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next investigated whether expression of CD4, CXCR4, or CCR5 by B cells was related to trans infection of T cells. As shown in Figure 2B and in the literature [28], low numbers of unstimulated B cells in blood express very low levels of CD4. Moreover, expression of CD4 was down-regulated after stimulation of the B cells with IL-4 and CD40L for 24 h (Figure 2B). We next demonstrated that activated B cells enhanced trans infection of CD4+ T cells with a low MOI of the HIV-1 R5 tropic, Ba-L strain (Figure 4C), comparable to HIV-1 X4, even though B cells do not express CCR5 (Figure 2B) [28]. Moreover, cis infection of either unstimulated B cells (unpublished data), stimulated B cells (Figure 4C), or T cells (Figure 4C) with HIV-1 R5 at this low MOI did not result in virus replication.
###end p 24
###begin p 25
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b029">29</xref>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 93 100 <span type="species:ncbi:9606">persons</span>
###xml 191 196 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 345 350 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 360 367 <span type="species:ncbi:9606">persons</span>
###xml 383 388 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 586 591 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Taken together, our data indicate that IL-4- and CD40L-activated B cells from HIV-1-negative persons mediated efficient trans infection of autologous CD4+ T cells with either X4 or R5 tropic HIV-1. Furthermore, this trans infection was not related to CD4, CXCR4, or CCR5 expression on the B cells. The fact that these were purified B cells from HIV-1-negative persons indicates that HIV-1 immune complexes and other types of cells were not involved in this process. It should also be noted that we did not include the lectin polybrene, a commonly used, receptor-independent enhancer of HIV-1 infection [29], in any of the cultures.
###end p 25
###begin title 26
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
B Cell-Mediated Transmission of HIV-1 to T Cells Is Dependent on Expression of DC-SIGN by the B Cells
###end title 26
###begin p 27
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 401 409 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g005">Figure 5</xref>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 535 543 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g005">Figure 5</xref>
###xml 794 796 794 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 821 823 821 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 825 833 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g005">Figure 5</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b030">30</xref>
###xml 1107 1108 1107 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1124 1125 1124 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 242 247 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 510 515 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 657 662 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 732 737 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 885 904 <span type="species:ncbi:37296">human herpesvirus 8</span>
###xml 1064 1069 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Based on the above results, we reasoned that DC-SIGN could be involved in B cell-mediated trans infection of T cells. To address this hypothesis, we first examined the relationship between DC-SIGN expression on purified B cells and uptake of HIV-1. Virus was expressed together with DC-SIGN in activated B cells after 2 h of exposure of the cells to virus as detected by immunofluorescent microscopy (Figure 5A). Quantitative immunofluorescence analysis by flow cytometry showed that 80% of B cells expressing HIV-1 p24 were DC-SIGN+ (Figure 5B). Our results also demonstrated that there was no alteration of DC-SIGN expression by B cells or DC loaded with HIV-1, although there was minimal down-regulation of DC-SIGN expression on HIV-1-infected, Raji-DC-SIGN cells by 24 h, using an MOI of 10-4 (unpublished data) or 10-3 (Figure 5C). This is in contrast to our recent findings that human herpesvirus 8 infects DC and macrophages via DC-SIGN and results in loss of surface expression of DC-SIGN [30]. Thus, after exposure of IL-4- and CD40L-activated B cells to HIV-1, the virus is associated with DC-SIGN+ but not DC-SIGN- B cells, and there is no alteration in DC-SIGN expression in these cells as detected by flow cytometry.
###end p 27
###begin p 28
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 554 563 554 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g006">Figures 6</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g006">6</xref>
###xml 653 661 653 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g006">Figure 6</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b017">17</xref>
###xml 918 923 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 312 317 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 324 329 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 440 445 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 594 599 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 828 833 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next determined the role of DC-SIGN on B cells in trans infection of T cells by treating IL-4- and CD40L-activated B cells with anti-DC-SIGN mAb or two nonspecific IgG as controls, one with the same isotype as the anti-DC-SIGN mAb (IgG2b) and the other of a different isotype (IgG1), prior to incubation with HIV-1 X4 or HIV-1 R5 and co-culture with T cells. The results show that pretreatment of B cells with anti-DC-SIGN mAb inhibited HIV-1 X4 and R5 replication in the B-T cell co-cultures, whereas pretreatment with the control IgG had no effect (Figures 6A and 6B). Also, inhibition of HIV-1 transmission by anti-DC-SIGN mAb was dose-dependent (Figure 6C). Because T cells do not express DC-SIGN [17], this virus-inhibitory effect was related to blocking of DC-SIGN on the activated B cells. These results indicate that HIV-1 X4 and R5 strains can be associated with B cells via DC-SIGN and that this leads to trans infection of T cells.
###end p 28
###begin p 29
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g002">Figure 2</xref>
###xml 217 225 217 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g002">Figure 2</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b028">28</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b031">31</xref>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 662 670 662 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g006">Figure 6</xref>
###xml 131 136 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 210 215 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 282 287 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 346 351 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 535 540 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although activated B cells did not express the primary CD4 receptor or the CCR5 coreceptor necessary for conventional infection by HIV-1 R5 (Figure 2B), they did express high levels of the CXCR4 coreceptor for HIV-1 (Figure 2B) [28]. Even though this is an inefficient receptor for HIV-1 infection in the absence of CD4 [31], we examined whether HIV-1 X4 trans infection of T cells was related to CXCR4 expression on the B cells. We treated activated B cells with anti-CXCR4 mAb or an IgG control, and showed that this did not inhibit HIV-1 X4 trans infection of T cells, whereas trans infection was blocked by pretreatment of the B cells with anti-DC-SIGN mAb (Figure 6D).
###end p 29
###begin p 30
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 344 345 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 434 442 432 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g007">Figure 7</xref>
###xml 667 675 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g007">Figure 7</xref>
###xml 692 697 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 823 824 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 854 855 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 910 918 908 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g007">Figure 7</xref>
###xml 1110 1115 1108 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Taken together, these results show that DC-SIGN expression on purified, IL-4- and CD40L-activated, peripheral blood B cells is directly related to trans infection of T cells. We hypothesized that this process could occur during B-T cell interactions in lymphatic tissues. In support of this, we found that DC-SIGN was expressed by 26.4 +/- 6% (n = 5) of single-cell suspensions of purified tonsil B cells (representative example, T0, Figure 7A). In contrast to blood B cells, there was little coexpression of CD23 by freshly purified, tonsil B cells, but comparable up-regulation of CD23 and coexpression with DC-SIGN after 24-h stimulation with IL-4 and CD40L (T24, Figure 7A). Importantly, trans infection of T cells was mediated by the stimulated tonsil B cells, as demonstrated by an increase in p24 levels from <1 x 101 pg per ml at day 4 to >3 x 103 pg per ml at days 8 to12 in the B-T cell co-cultures (Figure 7B). Over 90% of this virus replication was blocked by pretreatment of the B cells with anti-DC-SIGN mAb. Thus, both DC-SIGN expressing blood and lymphatic tissue B cells can mediate efficient trans infection of T cells.
###end p 30
###begin title 31
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Is Internalized in Activated B Cells
###end title 31
###begin p 32
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b003">3</xref>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 509 517 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g008">Figure 8</xref>
###xml 637 645 631 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g008">Figure 8</xref>
###xml 784 792 772 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g008">Figure 8</xref>
###xml 1006 1014 994 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g008">Figure 8</xref>
###xml 1018 1019 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b003">3</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 136 141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 268 273 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 349 354 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 502 507 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 554 559 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 687 692 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 993 998 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 is predominantly found within cytoplasmic vacuoles in DC after binding to DC-SIGN [3]. This could relate to different pathways of HIV-1 that are required for subsequent trans infection of T cells. We therefore conducted a series of experiments to assess whether HIV-1 was internalized by B cells. We first examined the physical association of HIV-1 with purified, activated B cells and DC by electron microscopy. As expected, no viral particles were observed in activated B cells not loaded with HIV-1 (Figure 8A). Activated B cells incubated with HIV-1 for 1 h at 4 degreesC had viral particles bound only to their outer surface (Figure 8B). However, activated B cells exposed to HIV-1 for 2 h at 37 degreesC had viral particles internalized in vacuoles of the cell cytoplasm (Figure 8C), with no intracellular virus apparent outside of vacuoles. Both intact viral particles and possible degraded virions were present in the vacuoles, similar to those observed after internalization of HIV-1 in DC (Figure 8D; [3]).
###end p 32
###begin p 33
###xml 702 710 696 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g008">Figure 8</xref>
###xml 1081 1089 1063 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g008">Figure 8</xref>
###xml 1413 1418 1377 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 22 27 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 166 171 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 394 399 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 903 908 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1155 1160 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1281 1286 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1335 1340 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1469 1474 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To prove further that HIV-1 particles were localized inside B lymphocytes and not merely bound to their surface, we incubated activated B cells with AT-2 inactivated HIV-1 X4 particles for 2 h at 37 degreesC to allow internalization, and then treated the cells with trypsin to cleave virions still bound on the cell surface. The culture medium was removed, and the cells were washed and lysed. HIV-1 p24 contained in the wash supernatants and cell lysates was measured by enzyme-linked immunosorbent assay (ELISA). Under these conditions, essentially all of the p24 was found in the whole cell lysate, as very little was detected in the cell culture supernatants collected after the trypsin treatment (Figure 8E). To prove that internalized virus and not surface-bound virus was transferred from B cells to the T cells, we next performed a protease protection transmission assay. Cells were loaded with HIV-1 R5 at 4 degreesC (wet ice) for 1 h, washed, and then shifted to 37 degreesC for the times indicated prior to treatment with trypsin or medium (mock treatment). As shown in Figure 8F, very brief proteolysis of the B cells that had been exposed to HIV-1 at 4 degreesC to inhibit virus entry and then shifted to 37 degreesC (i.e., 0 min incubation) prevented transmission of HIV-1 to the T cells. In contrast, proteolysis of the HIV-1-loaded B cells after shifting to 37 degreesC for 30 min did not prevent trans infection of the T cells. These data support that HIV-1 was internalized by the activated B cells prior to transmission to T cells.
###end p 33
###begin p 34
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b032">32</xref>
###xml 366 374 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g009">Figure 9</xref>
###xml 380 381 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g009">9</xref>
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 107 112 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 208 213 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 414 419 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 565 570 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 632 637 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Finally, we examined the ability of HIV-1 to remain infectious in B cells over time, as has been shown for HIV-1 infection of DC [32]. For this, we exposed activated B cells to infectious X4 or R5 strains of HIV-1 for 2 h at 37 degreesC, and then either mixed them immediately with T cells or kept them at 37 degreesC for 2 d before mixing with T cells. As shown in Figure 9A and 9B, B cells that were loaded with HIV-1 and cultured alone for 2 d could still transmit virus to T cells, although at a lower efficiency then when T cells were added immediately to the HIV-1-exposed B cells. Taken together, these results indicate that HIV-1 was captured and internalized in activated B cells, where it remained infectious for T cells for at least 2 d.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 281 282 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 433 436 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 796 797 796 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 903 904 903 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b019">19</xref>
###xml 1020 1021 1020 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1343 1345 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b016">16</xref>
###xml 1417 1422 1417 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1439 1440 1439 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1535 1540 1535 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 150 155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 238 243 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 538 543 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 604 609 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 672 677 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 774 779 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 985 990 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1127 1132 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1487 1492 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our results demonstrate that activated B lymphocytes derived from peripheral blood and lymphatic tissue express DC-SIGN, and that these cells mediate HIV-1 trans infection of T lymphocytes. Evidence for trans infection was an increase of HIV-1 p24 from undetectable levels (<1 x 101 pg/ml) to >103-104 pg/ml after 12-16 d of co-culture of the activated B cells with autologous CD4+ T cells. The trans infection was not due to direct cis infection of the B cells, as virus replication was not detectable in B cells alone after exposure to HIV-1. Likewise, there was little or no detectable replication of HIV-1 after direct infection of T cells alone with the low input of HIV-1 used in our experiments. Expression of DC-SIGN by the B cells was associated with this enhanced HIV-1 infection of CD4+ T cells in trans. That is, treatment with IL-4 and CD40L, which are mediators of B cell activation by CD4+ T cells [19], enhanced DC-SIGN expression on the B cells. A total of 80% of the HIV-1-infected B cells were DC-SIGN+ by flow cytometry. This was supported by immunofluorescence microscopy analysis showing that DC-SIGN and HIV-1 were coexpressed in the B cell cytoplasm. Association of virus with a small portion of non-DC-SIGN-expressing B cells could be related to expression of other C-type lectin receptors by B cells that bind gp120 [16]. Most importantly, DC-SIGN expression by the B cells was required for trans infection of CD4+ T cells with both X4 and R5 tropic strains of HIV-1, as we could block essentially all of the trans infection by pretreating the B cells with mAb specific for DC-SIGN.
###end p 36
###begin p 37
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b025">25</xref>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 669 674 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b016">16</xref>
###xml 862 867 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 228 233 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 357 362 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In further support of a central role for DC-SIGN on B cells in HIV-1 trans infection, we found that the number of DC-SIGN molecules expressed on activated B cells was similar to that known to be sufficient to sustain capture of HIV-1 and trans infection of T cells by DC [25]. Notably, the mechanism of trans infection of T cells by B cells did not involve HIV-1 infection of B cells by the conventional, CD4-CXCR4/CCR5 pathway. This was supported by the fact that B cells expressed little or no CD4 and did not express CCR5. Moreover, although B cells expressed high levels of CXCR4, treatment with anti-CXCR4 mAb prior to virus binding to the B cells did not inhibit trans infection of the T cells. Thus, although other C-type lectin receptors are expressed on B cells and can bind gp120 [16], our results support a requirement for DC-SIGN in B cell-mediated, trans infection of T cells.
###end p 37
###begin p 38
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b003">3</xref>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 552 557 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b033">33</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b032">32</xref>
###xml 1043 1044 1043 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b003">3</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b034">34</xref>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b003">3</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b035">35</xref>
###xml 1285 1286 1285 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b003">3</xref>
###xml 1287 1289 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b035">35</xref>
###xml 1476 1481 1476 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1610 1615 1610 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 304 309 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 503 508 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 621 626 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1266 1271 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1346 1351 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1604 1609 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 was internalized by B cells as determined by resistance of B cell-associated virus to treatment with trypsin, and predominance of virus particles in cytoplasmic vacuoles of B cells after binding to DC-SIGN. Both intact and apparently degraded particles were present within the vacuoles, similar to HIV-1 internalization in DC via DC-SIGN [3]. Internalized and not extracellularly bound virus resulted in trans infection of T cells, which was demonstrated by lack of effect of trypsin treatment of HIV-1-loaded B cells on their ability to mediate trans infection. These results suggest a role for internalization of HIV-1 by B cells that is similar to that of DC in trans infection of T cells [33]. We further observed that virus was maintained for at least 2 d in an infectious form in B cells, comparable to its association with DC [32]. It is not clear how this virus infectivity persists. Recent studies indicate that most of the captured virions are destroyed in DC-SIGN-expressing DC and B cell lines engineered to express DC-SIGN [3,34]. However, a portion of the input virus can rapidly trans infect T cells [3,35]. In contrast, the longer term, persistent infectivity of DC-SIGN-expressing DC and B cell lines has been related to low levels of de novo HIV-1 replication [3,35]. It is possible that very low, subdetectable levels of HIV-1 replication occurred in our IL-4- and CD40L-stimulated B cells, and resulted in persistence of infectious virus involved in trans infection of T cells. Further work is in progress to delineate the mechanisms by which DC-SIGN-expressing B cells lead to HIV-1 trans infection of T cells.
###end p 38
###begin p 39
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b006">6</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b010">10</xref>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b011">11</xref>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 699 700 699 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 189 194 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 358 363 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 428 433 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 452 459 <span type="species:ncbi:9606">persons</span>
The DC-SIGN-mediated, B-to-T cell trans infection pathway appears to be distinct from previously described B-T cell infectious processes. That is, it has been reported that transmission of HIV-1 from B cells to T cells involves virus trapped in immune complexes on the surface of the B cells [6-10]. This is not involved in our system, since in our studies, HIV-1 trans infection of T cells was mediated by B cells from normal, HIV-1 antibody-negative persons. Finally, in contrast to Swingler et al. [11], where nef-induced soluble factors released by infected macrophages work together with B cells to lead to trans infection of T cells, we observed trans infection of T cells by purified, DC-SIGN+ B cells in the absence of macrophages.
###end p 39
###begin p 40
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1138 1139 1138 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b036">36</xref>
###xml 1323 1325 1323 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b037">37</xref>
Notably, we found that approximately 8% of B cells in the blood of normal donors expressed DC-SIGN. Stimulation for 24 h with IL-4 and CD40L resulted in an increase in the number of B cells expressing DC-SIGN (i.e., 28%) and the level of DC-SIGN expression on the B cells. Approximately 80% of the DC-SIGN+ B cells in blood also expressed the type II C-type lectin receptor and B cell activation marker, CD23, which increased to 86% after stimulation in vitro with IL-4 and CD40L. Activation of these stimulated, DC-SIGN+ B cells was confirmed by elevated levels of T cell coreceptors CD58, CD80, and CD86, as well as increases in coexpression of the B cell signal transduction molecule CD22. Expression of DC-SIGN was not restricted to blood B cells, as we found that approximately 26% of tonsil B cells constitutively expressed DC-SIGN, and that this increased to 39% after stimulation of the cells with IL-4 and CD40L. Interestingly, our study showed that few B cells directly isolated from the tonsils expressed CD23, but that this number increased after stimulation with IL-4 and CD40L. Expression of CD23 on some but not all DC-SIGN+ B cells could be related to differential expression of CD23 by B cells in distinct areas of tonsils [36], and a pronounced cleavage and shedding of soluble CD23 by activated B cells [37].
###end p 40
###begin p 41
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b006">6</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b038">38</xref>
###xml 107 114 <span type="species:ncbi:9606">persons</span>
###xml 140 145 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 257 262 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 291 296 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 458 465 <span type="species:ncbi:9606">persons</span>
Of interest is that there was a comparable number of DC-SIGN-expressing B cells in the blood of uninfected persons as in those with chronic HIV-1 infection who were treatment naive or receiving ART. In support of these findings, although B cells can harbor HIV-1 in blood [6], we found that HIV-1 did not kill B cells or inhibit DC-SIGN expression within 24-48 h of exposure to virus in vitro. Our observation that IL-4 and CD40L stimulation of B cells from persons receiving ART failed to enhance expression of DC-SIGN suggests a negative effect of ART on this process. This could be related to the reported inhibitory effect of protease inhibitors, which are common components of ART, on expression of DC-SIGN [38], and requires further study.
###end p 41
###begin p 42
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b039">39</xref>
Expression of DC-SIGN on B cells suggests that it is operative in their normal function. This type II C-type lectin receptor could be involved in B cell trafficking and antigen presentation to T cells, similar to its function in DC [39]. Indeed, high levels of expression of DC-SIGN were induced in B cells by a combination of T cell factors IL-4 and CD40L and not by either alone. These results support the concept that DC-SIGN is involved in the interaction of activated B and T cells during antigen processing and presentation.
###end p 42
###begin p 43
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b040">40</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b041">41</xref>
###xml 478 479 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b042">42</xref>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b028">28</xref>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 179 184 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 597 626 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 876 881 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 975 980 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our data indicate that DC-SIGN-expressing B cells could become vehicles for HIV-1 infection of T cells during their cognate interactions in the lymphatics. High concentrations of HIV-1 have been found associated with B cells and CD4+ T cells in lymph nodes [40], where B cells are activated and proliferate through cytokine and CD40L-CD40 interactions [41]. This has been related to virus-containing immune complexes on the surface of B cells that could lead to infection of CD4+ T cells during "cross talk" in the microenvironment of lymphoid tissues. The presence of a large amount of unspliced simian immunodeficiency virus RNA in B cell-rich areas of lymphoid tissues [42], is also consistent with virions being associated with B cells and follicular DC in germinal centers. B cells have therefore been proposed as an important, lymphatic reservoir in the pathogenesis of HIV-1 [28]. Our results suggest that B cells play a previously unrecognized role in replication of HIV-1 in T cells and viral pathogenesis through a DC-SIGN-dependent mechanism.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
Donors.
###end title 45
###begin p 46
###xml 53 54 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 320 321 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 447 448 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 462 463 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 569 570 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 65 70 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 247 252 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 351 356 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 411 416 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 526 531 <span type="species:ncbi:9606">Human</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
PBMC were obtained from healthy, HIV-1-seronegative (n = 33) and HIV-1-seropositive (n = 20) adult volunteers and subjects enrolled in the Multicenter AIDS Cohort Study. Informed consent was obtained following institutional guidelines. ART-naive, HIV-1-seropositive subjects (n = 10) had mean (+/- SE) of 658 +/- 124 CD4+ T cells per ml of blood, and HIV-1 RNA loads of 6,410 +/- 3,701 copies per ml of plasma; HIV-1-seropositive subjects on ART (n = 10) had CD4+ T cell counts of 939 +/- 82 and viral RNA loads of 66 +/- 20. Human tonsils were obtained from patients (n = 5) undergoing therapeutic surgery, in accordance with institutional guidelines.
###end p 46
###begin title 47
Preparation of B and T cells.
###end title 47
###begin p 48
###xml 327 328 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 562 563 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 629 630 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 638 639 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 772 773 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 819 820 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 825 826 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 842 843 838 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 962 963 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1204 1205 1200 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1332 1334 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b043">43</xref>
PBMC were isolated by Ficoll-Hypaque density gradient separation and used immediately for surface phenotype staining or further purification. For B cell purification, monocytes were depleted with two rounds of anti-CD14 mAb-coated immunomagnetic microbeads (Miltenyi) according to the manufacturer's instructions. B cells (CD19+ cells) were then isolated from the CD14- cell fraction by incubation with anti-CD19 mAb-coated, magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of the fractionated B cells was 96.4% +/-0.4 (mean +/- SE; n = 33) as determined by staining with anti-CD20 mAb, with <1% CD14+ and CD3+ cells. The immunomagnetic bead purification procedure did not alter expression of DC-SIGN or CD23 (unpublished data). Autologous CD4+ T cells were obtained from the remaining CD14- CD19- fraction by CD4+ cell purification using anti-CD4 mAb-coated microbeads (Miltenyi). Activated B cells were generated by culture of CD19+ cells in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 1,000 U/ml of rhIL-4 (R & D Systems, Minneapolis, Minnesota, United States), and 1 ug/ml of soluble trimeric CD40 L (Amgen, Thousand Oaks, California, United States). CD4+ T lymphocytes were cultured in RPMI1640 medium supplemented with 20% FCS and phytohemagglutinin (PHA) and IL-2, as described [43].
###end p 48
###begin p 49
Tonsils were immediately transferred to the laboratory in cold PBS supplemented with penicillin (100 U/ml), streptomycin (100 mug/ml), gentamicin (5 mug/ml), ampothericin B (0.5 mug/m), and 5% FCS. The tissues were cut into fragments and pushed through a stainless steel sieve with a 250-mum mesh, using the flat end of a plastic syringe plunger, to remove the connective capsula. Lymphocytes from the collected cell suspension were isolated by Ficoll-Hypaque density gradient centrifugation. The cells collected at the interface were stained with anti-CD20, anti-CD3, and anti-CD14 mAb to determine the relative percentage of B and T lymphocytes, and were shown to contain 60%-70% B lymphocytes, 30%-40% T lymphocytes, and 1 % or less monocytes. B and T cells were purified by immunomagnetic bead separation and activated as described above.
###end p 49
###begin title 50
Preparation of DC.
###end title 50
###begin p 51
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b044">44</xref>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
DC were generated from CD14+ cells as described [44]. Briefly, CD14+ cells were enriched from PBMC with anti-CD14 mAb magnetic beads (>95% lineage negative, HLA DR+ cells) and cultured for 5 d in the presence of 1,000 U/ml of rhIL4 and rGM-CSF.
###end p 51
###begin title 52
Antibodies.
###end title 52
###begin p 53
###xml 347 352 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 739 744 <span type="species:ncbi:10090">mouse</span>
The following mAbs were used in this study: anti-DC-SIGN (CD209) (clone 120507; R & D Systems); anti-CD4, anti-CD14, anti-CD19, anti-CD20, anti-CD22, anti-CD45, anti-CD58, anti-CD80, anti-CD86, anti-CXCR4, and CCR5 (BD Pharmingen, San Diego, California, United States); anti-CD23 (Caltag Laboratories, Burlingame, California, United States); anti-HIV-1 p24 (KC57; Beckman-Coulter, Fullerton, California, United States). These mAbs were used either unlabeled or conjugated with FITC, PE, PE-Cy5, or PE-Cy7 as indicated below. Appropriate isotype-matched controls were used for background staining evaluation. For the virus receptor blocking experiments, we used sodium azide-free, low-endotoxin, purified, anti-DC-SIGN clone 120507 mAb and mouse IgG of the relevant isotype (Becton Dickinson, Palo Alto, California, United States) reconstituted in sterile PBS.
###end p 53
###begin title 54
Flow cytometry and quantification of DC-SIGN expression.
###end title 54
###begin p 55
###xml 271 272 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 402 407 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 466 471 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Expression of cell surface molecules was examined by flow cytometry with a Beckman Coulter XL flow cytometer. Cells were incubated with the desired antibodies or isotype controls for 30 min at 4 degreesC in buffer consisting of PBS supplemented with 0.1% FCS and 0.1% NaN3. After extensive washing with the buffer, the cells were resuspended in 1% paraformaldehyde in PBS for flow cytometric analysis. HIV-1 intracellular p24 was identify using PE-labeled KC57 anti-HIV-1 Gag mAb, following cell permeabilization using Permiflow (Invirion Diagnostics, Oak Brook, Illinois, United States) according to manufacturer's instructions. Results were expressed either as percent positive cells above the isotype control threshold or as MFI above the isotype controls.
###end p 55
###begin p 56
###xml 413 417 <span type="species:ncbi:9925">goat</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
For quantification of DC-SIGN expression on DC, Raji-DC-SIGN cells, and activated B cells, we used the Quantum Simply Cellular kit (Bangs Laboratories, Fishers, Indiana, United States) according to the manufacturer's instructions. Quantification was performed by converting the geometric mean channel fluorescence (GMCF) into ABC. The kit contains five microbeads of uniform size coated with different amounts of goat anti-mouse IgG (Fc-specific) on their surface that have different abilities to bind mouse antibodies (ranging from 0 to about 250,000 molecules). Both beads and cells were labeled with saturating amounts of FITC-conjugated, anti-DC-SIGN mAb, processed, and analyzed by flow cytometry under identical conditions. A calibrating curve was derived from the bead samples using QuickCal (Bangs Laboratories). The GMCF of the samples was converted to ABC per cell by comparison with the regression curve generated with the beads. Samples were also evaluated for fluorescence intensity as expressed by MESF units, using the Quantum MESF kit (Bangs Laboratories). The kit consists of five bead populations having different levels of FITC fluorescence intensity. As described above, a regression curve was generated by plotting the GMCF of the beads against their known MESF using QuickCal. The MESF of the cell samples was then determined as described above for ABC.
###end p 56
###begin title 57
Real-time RT-PCR measurement of DC-SIGN mRNA.
###end title 57
###begin p 58
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b023">23</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b024">24</xref>
###xml 1106 1108 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b024">24</xref>
###xml 1438 1439 1427 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Total RNA was extracted from cells using Trizol (Invitrogen Life Sciences, Carlsbad, California, United States) according to the manufacturer's instructions, DNAse-treated (Ambion, Austin, Texas, United States) and affinity column purified (RNAeasy, Qiagen, Valencia, California, United States). The sequences of the primers and probe for Taqman amplification and detection of DC-SIGN mRNA were kindly provided by B. Lee (University of California, Los Angeles) and were DC-SIGN.F1, 5'-GCTGAGAGGCCTTGGATTCC-3'; DC-SIGN.R1, 5'-AGAGCGTGAAGGAGAGGAGTTG-3'; and DC-SIGN.probe, 5'-6FAM-ACCATGGCCAAGACACCCTGCTA -MGB-3'. The comparative threshold cycle (Ct) method [23,24] was used to determine relative mRNA expression levels. The primer and probe set for beta-glucoronidase (beta-GUS) (Applied Biosystems, Foster City, California, United States) was used as the endogenous control. Across all samples, mean beta-GUS Ct values were 29 +/- 1 (unpublished data). cDNA synthesis with 400-ng input RNA was performed in duplicate with Superscript II reverse transcriptase (Invitrogen) and random hexamers as described [24], in parallel with control reactions lacking RT. Amplification and detection for 40 cycles was performed on a Prism 7000 Sequence Detection System (Applied Biosystems). The fold-changes in DC-SIGN mRNA expression were calculated relative to appropriate calibrator samples, including untransfected K562 cells and unstimulated CD19+ B cells.
###end p 58
###begin title 59
Virus.
###end title 59
###begin p 60
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b043">43</xref>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 317 318 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 324 325 322 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 33 36 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 IIIb (X4 tropic virus) and HIV-Ba-L (R5 tropic virus) were propagated in PHA- and IL-2-activated, normal donor PBMC and purified as described [43]. Virus titers were determined as pg/ml by p24 ELISA (DuPont, Wilmington, Delaware, United States), with a lower limit of 1 x 101 pg/ml and upper limit of >/= 5 x 104 pg/ml. AT-2-inactivated HIV-1 MN (CL.4/SUPT1; X4 tropic), and ADA (M/SUPT1-CCR5 CL.30; R5 tropic) were a gift from J. D. Lifson, National Cancer Institute, Frederick, Maryland.
###end p 60
###begin title 61
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infection and transmission assay.
###end title 61
###begin p 62
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 142 144 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 151 153 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 269 270 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1094 1096 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020070-b030">30</xref>
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 116 121 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 594 599 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 797 802 <span type="species:ncbi:10090">mouse</span>
Purified, IL-4- and CD40L-stimulated B lymphocytes (1 x 106) were incubated with different amounts of HIV-1 IIIb or HIV-1 Ba-L, i.e., 10-3, 10-4, or 10-5 MOI at 37 degreesC for 2 h. The MOI was based on tissue culture infectious dose 50% determined with susceptible CD8-, PHA-stimulated human lymphocytes and confirmed by spectrophotometric analysis of 10-fold serial dilutions on TZM-bl indicator cell line. Unless otherwise specified, cell-free supernatants were taken at various time intervals for titration of virus by p24 ELISA. No difference was observed in viability of mock-treated and HIV-1-treated B cells as measured by trypan blue dye exclusion. In some experiments, stimulated B cells were incubated with anti-DC-SIGN mAb (clone 120507) or CD11a/LFA-1 (clone HI111, BD Pharmingen) or mouse IgG (R & D Systems) for 30 min at 4 degreesC prior to incubation with virus. The specificity of anti-DC-SIGN mAb clone 120507 was confirmed by binding to DC-SIGN-transfected K-562 cells and lack of binding to K562 cells transfected with the DC-SIGN-related, type II C-type lectin, DC-SIGNR [30] .
###end p 62
###begin title 63
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Loading of DC and activated B cells with HIV-1 for electron microscopy.
###end title 63
###begin p 64
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 482 483 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 489 490 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 105 110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A total of 1 x 106 DC or purified, activated B cells were incubated in a 1.5-ml Eppendorf tube with AT-2 HIV-1 (3 ng of p24 Ag /106 cells) in a total volume of 100 mul at 37 degreesC for up to 2 h. After the incubation, cells were extensively washed in cold medium using a refrigerated microfuge, and the cell pellets were fixed in PBS with 2.5% glutaraldehyde for 1 h. Pellets were washed three times in PBS and then post-fixed in 1% aqueous osmium tetroxide supplemented with 1% K3Fe(CN)6 for 1 h. Pellets were then washed three times in PBS and then dehydrated through a series of 30%-100% ethanol, 100% propylene oxide, and then infiltrated with 1:1 mixture of propylene oxide-Polybed 812 epoxy resin (Polysciences, Warrington, Pennsylvania, United States) for 1 h. After several changes of 100% resin over 24 h, the pellet was embedded in a final change of resin, cured at 37 degreesC overnight, followed by additional hardening at 65 degreesC for two more days. Ultrathin (70 nm) sections were collected onto 200-mesh copper grids, stained with 2% uranyl acetate in 50% methanol for 10 min, followed by 1% lead citrate for 7 min. Sections were viewed using a JEM 1210 electron microscope (JEOL, Peabody, Massachusetts, United States).
###end p 64
###begin title 65
Immunofluorescence microscopy.
###end title 65
###begin p 66
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 322 327 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 567 572 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Purified, activated B cells loaded with AT-2 HIV-1 MN were spotted on poly-L-lysine-coated slides, fixed with 4% paraformaldehyde for 20 min, and then permeabilized with buffer (0.5% BSA, 0.1% saponin, 0.1%NaN3) for 20 min at room temperature. Cells were stained with FITC-conjugated, anti-DC-SIGN mAb and PE-labeled anti-HIV-1 p24 mAb. To avoid nonspecific binding of IgG, all incubations and dilutions of reagents were done in Super-Block blocking buffer (Pierce Biotechnology, Rockford, Illinois, United States). Controls included activated B cells not exposed to HIV-1.
###end p 66
###begin title 67
Supporting Information
###end title 67
###begin title 68
CD40L and IL-4 Act Synergistically in Inducing Enhanced DC-SIGN and CD23 Expression on B Cells
###end title 68
###begin p 69
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Coexpression of DC-SIGN and CD23 on B cells from healthy, HIV-1-seronegative donors (n = 20). Hour 0 [T0] = 0 h; hour 24 [T24] = 24 h.
###end p 69
###begin p 70
(B) Time-dependent expression of DC-SIGN and CD23 in response to IL-4 and CD40L. Purified B cells from a normal donor were cultured in the presence of IL-4 or CD40L or a combination of the two. Untreated cells were used as controls (NT). DC-SIGN and CD23 coexpression on activated B cells was greatest using a combination of 1,000 U/ml of IL4 and 1 mug/ml of CD40L for 24 h. Single concentrations of 100, 500, and 10,000 U/ml of IL-4 and 0.1, 0.5, and 10 mug/ml of CD40L induced similar, low levels of DC-SIGN expression (unpublished data). Also, various combinations of these concentrations of IL-4 and CD40L induced less DC-SIGN expression than this combination (unpublished data).
###end p 70
###begin p 71
(380 KB JPG)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin title 73
Accession Numbers
###end title 73
###begin p 74
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
The GenBank accession number () for the gene mentioned in this paper is CD209 (NM_021155).
###end p 74
###begin p 75
###xml 542 547 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 608 611 <span type="species:ncbi:9606">Men</span>
The authors wish to thank R. Jaffe, L. Schmitt, H. Cicco, V. Ayyavoo, S. Sanghavi, A. Hoji, and M. Tomasewski for assistance and helpful advice; D. Stoltz for assistance with the electron microscopy; M. White for the p24 ELISA tests; B. Lee of the University of California, Los Angeles, for the DC-SIGN primer and probe sequences; A. Donnenberg for assistance with the flow cytometry cell sorting; Amgen for the gift of CD40L (MTA n.200312724), and K. Phalmer (Amgen) for assistance; and J. D. Lifson (National Cancer Institute) for the AT-2 HIV-1 preparations. The authors extend special thanks to the Pitt Men's Study/Multicenter AIDS Cohort Study staff and volunteers.
###end p 75
###begin title 76
Abbreviations
###end title 76
###begin p 77
antibody binding capacity
###end p 77
###begin p 78
antiretroviral therapy
###end p 78
###begin p 79
CD40 ligand
###end p 79
###begin p 80
dendritic cell
###end p 80
###begin p 81
DC-specific ICAM-3 grabbing nonintegrin
###end p 81
###begin p 82
enzyme-linked immunosorbent assay
###end p 82
###begin p 83
interleukin
###end p 83
###begin p 84
monoclonal antibody
###end p 84
###begin p 85
molecules of equivalent soluble fluorochrome
###end p 85
###begin p 86
mean fluorescence intensity
###end p 86
###begin p 87
multiplicity of infection
###end p 87
###begin p 88
peripheral blood mononuclear cells
###end p 88
###begin p 89
standard error
###end p 89
###begin title 90
References
###end title 90
###begin article-title 91
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
###end article-title 91
###begin article-title 92
Pathogens target DC-SIGN to influence their fate. DC-SIGN functions as a pathogen receptor with broad specificity
###end article-title 92
###begin article-title 93
###xml 65 70 <span type="species:ncbi:9606">human</span>
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells
###end article-title 93
###begin article-title 94
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
B lymphocyte dysfunctions in HIV infection
###end article-title 94
###begin article-title 95
Cell surface receptors, virus entry and tropism of primate lentiviruses
###end article-title 95
###begin article-title 96
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells
###end article-title 96
###begin article-title 97
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma
###end article-title 97
###begin article-title 98
###xml 28 63 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes
###end article-title 98
###begin article-title 99
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures
###end article-title 99
###begin article-title 100
###xml 104 109 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection
###end article-title 101
###begin article-title 102
###xml 135 140 <span type="species:ncbi:9606">human</span>
The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family
###end article-title 102
###begin article-title 103
Dendritic cell-associated lectin-1: A novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4
###end article-title 103
###begin article-title 104
APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif
###end article-title 104
###begin article-title 105
CD23 and B-cell activation
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors
###end article-title 106
###begin article-title 107
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
###end article-title 107
###begin article-title 108
###xml 10 15 <span type="species:ncbi:9606">human</span>
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40
###end article-title 108
###begin article-title 109
The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated differentiation of B lymphocytes
###end article-title 109
###begin article-title 110
DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents
###end article-title 110
###begin article-title 111
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN
###end article-title 111
###begin article-title 112
###xml 143 148 <span type="species:ncbi:9606">human</span>
Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages
###end article-title 112
###begin article-title 113
Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction
###end article-title 113
###begin article-title 114
###xml 26 61 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 72 101 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus
###end article-title 114
###begin article-title 115
###xml 17 20 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DC-SIGN: A novel HIV receptor on DCs that mediates HIV-1 transmission
###end article-title 115
###begin article-title 116
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes
###end article-title 116
###begin article-title 117
###xml 103 138 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
CD40-mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: Potential role of B lymphocytes as a viral reservoir
###end article-title 117
###begin article-title 118
###xml 39 67 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells
###end article-title 118
###begin article-title 119
###xml 26 45 <span type="species:ncbi:37296">human herpesvirus 8</span>
DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages
###end article-title 119
###begin article-title 120
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 coreceptor usage, transmission, and disease progression
###end article-title 120
###begin article-title 121
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cell type-dependent retention and transmission of HIV-1 by DC-SIGN
###end article-title 121
###begin article-title 122
###xml 36 39 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection
###end article-title 122
###begin article-title 123
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation
###end article-title 123
###begin article-title 124
###xml 7 35 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes
###end article-title 124
###begin article-title 125
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human marginal zone B cell
###end article-title 125
###begin article-title 126
Structure and functions of CD23
###end article-title 126
###begin article-title 127
###xml 4 7 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The HIV protease inhibitor indinavir reduces immature dendritic cell transendothelial migration
###end article-title 127
###begin article-title 128
DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking
###end article-title 128
###begin article-title 129
###xml 47 75 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 77 80 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection
###end article-title 129
###begin article-title 130
CD40 and CD154 in cell-mediated immunity
###end article-title 130
###begin article-title 131
A new approach to investigating the relationship between productive infection and cytopathicity in vivo
###end article-title 131
###begin article-title 132
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
###xml 67 70 <span type="species:ncbi:9606">men</span>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties
###end article-title 132
###begin article-title 133
###xml 99 118 <span type="species:ncbi:37296">human herpesvirus 8</span>
Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8
###end article-title 133
###begin title 134
Figures and Tables
###end title 134
###begin title 135
Expression of DC-SIGN on B Cells
###end title 135
###begin p 136
(A) B cells within the PBMC population expressed DC-SIGN. PBMC were assessed for expression of CD45, CD19, and DC-SIGN by flow cytometry. Cells coexpressing CD45 and CD19 (left) were analyzed for DC-SIGN coexpression (right). Quadrant positions were determined with the isotype controls.
###end p 136
###begin p 137
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 237 242 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(B) Increase in coexpression of DC-SIGN on CD20+ cells detected by flow cytometry in unstimulated, purified, fresh B cells (0 h; T0) and IL-4- and CD40L-stimulated, purified B cells at 24 h (T24). Data are from a representative, healthy HIV-1-seronegative donor.
###end p 137
###begin p 138
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 159 164 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(C) DC-SIGN expression on B cells from healthy, HIV-1-seronegative donors (n = 33, left), HIV-1-seropositive, ART therapy-naive subjects (n = 10, middle), and HIV-1-seropositive subjects receiving ART (n = 10, right). Quadrants were positioned on the isotype controls.
###end p 138
###begin p 139
(D) CD40L and IL-4 acted synergistically in inducing enhanced DC-SIGN expression in B cells by 24 h. In this representative experiment (top), purified B cells were cultured in the presence of IL-4 or CD40L or a combination of the two. Untreated B cells were used as controls (NT). DC-SIGN and CD20 coexpression on activated B cells was greatest using a combination of 1,000 U/ml of IL4 and 1 mug/ml of CD40L for 24 h (bottom). Single concentrations of 100, 500, and 2,000 U/ml of IL-4 and 0.1, 0.5, and 10 mug/ml of CD40L induced similar, low levels of DC-SIGN expression (unpublished data); various combinations of these concentrations of IL-4 and CD40L induced less DC-SIGN expression than this combination (unpublished data).
###end p 139
###begin title 140
Coexpression of DC-SIGN and Markers of Activation on B Cells
###end title 140
###begin p 141
Expression of CD20, CD22, CD23, CD58, CD80, and CD86 in purified, unstimulated ([A] time 0 h; T0) and IL-4- and CD40L-stimulated ([B] time 24 h; T24) B cells. The quadrants were set on the isotype controls. Expression of CD4, CXCR4, and CCR5 is shown for unstimulated (full histograms) and stimulated (24 h; red profile histograms), purified B lymphocytes. Isotype controls are indicated by gray lines. Data are from a single experiment representative of five independent experiments.
###end p 141
###begin title 142
Quantitation of DC-SIGN Expression on B Cells
###end title 142
###begin p 143
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
ABC and MESF (panels [A] and [B], respectively) of unstimulated (resting [rB]) and activated (aB) B cells and DC from six donors, and four independent samplings of Raji-DC-SIGN cells, were determined as described in Materials and Methods. p < 0.008 for ABC and p < 0.001 for MESF comparing rB to aB cells; p = NS comparing aB cells to DC or Raji-DC-SIGN cells. The red lines indicate the mean values for ABC and MESF. In panel (C), the histogram profiles of expression of DC-SIGN on activated B cells and DC from one representative donor are shown, as well as the profile of expression of DC-SIGN on Raji-DC-SIGN cells for comparison (full histograms: DC-SIGN positive cells, black line overlay histograms: isotype control).
###end p 143
###begin title 144
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activated B Cells Transmit HIV-1 X4 and R5 to T Cells
###end title 144
###begin p 145
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 292 293 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 170 175 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 348 353 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Levels of HIV-1 p24 in B cells stimulated with IL-4 and CD40L (activated B cells [aB]) or mock stimulated (resting B cells [rB]) for 24 h and loaded with 10-4 MOI of HIV-1 X4 (IIIb) for 2 h at 37 degreesC, then extensively washed in cold medium and incubated with purified, autologous CD4+ T cells (T). B cells and T cells directly loaded with HIV-1 served as controls.
###end p 145
###begin p 146
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 186 191 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(B) Dose response of HIV-1 trans infection shown by levels of p24 in cultures of autologous T cells (T) mixed with activated B cells (B) that were loaded with 10-5, 10-4, or 10-3 MOI of HIV-1 X4 (IIIb). The results shown are representative of three independent experiments with B and T cells from different donors.
###end p 146
###begin p 147
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(C) Activated B cells (B) transmitted both HIV-1 X4 (IIIb) and R5 (Ba-L) strains to autologous T cells (T) as shown by increases in levels of p24. T cells and B cells were separately cultured with either strain of virus as controls. Data are represented as the means of triplicates +/- SE, and are from single experiments representative of five or more independent experiments.
###end p 147
###begin title 148
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Expression of DC-SIGN and HIV-1 in B Cells
###end title 148
###begin p 149
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 146 151 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 199 204 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 297 302 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Immunofluorescent microscopy showing coexpression of DC-SIGN and HIV-1 in IL-4 and CD40L purified, activated B cells after 2 h of exposure to HIV-1 X4 (MN) at 37 degreesC. B cells not exposed to HIV-1 were used as controls; these included a subset that expressed DC-SIGN and were negative for HIV-1 (unpublished data). (600x magnification) Green indicates DC-SIGN, red indicates p24, and blue indicates DAPI.
###end p 149
###begin p 150
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(B) Flow cytometry histograms showing coexpression of DC-SIGN and HIV-1 in IL-4 and CD40L purified, activated B cells after 2 h of exposure to HIV-1 X4 (MN) at 37 degreesC.
###end p 150
###begin p 151
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 306 311 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(C) HIV-1 R5 (Ba-L) had no effect on expression of DC-SIGN by purified, activated B cells (left) or DC (middle), and minimally inhibited DC-SIGN expression in Raji-DC-SIGN cells (right) after 24 h incubation with the virus. Full histogram represents uninfected B cells; purple overlay histogram represents HIV-1-infected cells; and black overlay histogram represents isotype controls. Data are from single experiments representative of five independent experiments.
###end p 151
###begin title 152
###xml 32 35 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
B Cell-Mediated Transmission of HIV X4 and R5 to T Cells Is Blocked by Anti-DC-SIGN mAb
###end title 152
###begin p 153
###xml 142 150 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g006">Figure 6</xref>
###xml 167 175 167 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020070-g006">Figure 6</xref>
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 125 130 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) and (B) HIV-1 p24 levels in cultures of activated B cells that were treated with anti-DC-SIGN mAb, incubated with either HIV-1 X4 (IIIb) (Figure 6A) or R5 (Ba-L) (Figure 6B) for 2 h at 37 degreesC, washed and co-cultured with autologous T cells. B and T cells cultured alone with each virus were used as controls.
###end p 153
###begin p 154
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 139 144 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 275 280 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(C) HIV-1 p24 levels in cultures of activated B cells that were incubated with decreasing amounts of anti-DC-SIGN mAb prior to exposure to HIV-1 R5 (Ba-L) and culture with autologous T cells for 8 d. Treatment with mouse IgG or an unrelated mAb (anti-CD11a) had no effect on HIV-1 R5 (Ba-L) trans infection.
###end p 154
###begin p 155
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 125 130 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(D) HIV-1 p24 levels in cultures of activated B cells incubated with anti-DC-SIGN mAb or anti-CXCR4 mAb, washed, loaded with HIV-1 X4 (IIIb), and co-cultured with autologous T cells for 12 d.
###end p 155
###begin p 156
Data are represented as mean of triplicates +/- SE. Data are from single experiments representative of eight independent experiments.
###end p 156
###begin title 157
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
DC-SIGN-Expressing Tonsil B Cells Mediate trans Infection of T Cells
###end title 157
###begin p 158
(A) Expression of CD20 and DC-SIGN or CD23 and DC-SIGN in fresh (time 0 h; T0) and IL-4- and CD40L-activated (time 24 h; T24) B cells derived from tonsils. Data are from one experiment representative of five independent experiments.
###end p 158
###begin p 159
###xml 223 225 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 355 356 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
###xml 233 238 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 411 416 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 447 452 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(B) Levels of HIV-1 p24 in co-cultures of B and T cells derived from tonsils. B cells were stimulated with IL-4 and CD40L for 24 h, treated with anti-DC-SIGN mAb or mouse Ig (20 mug/ml) or left untreated, and loaded with 10-4 MOI of HIV-1 R5 (Ba-L) for 2 h at 37 degreesC, then extensively washed in cold medium and incubated with purified, autologous CD4+ T cells (T). B cells and T cells directly loaded with HIV-1 served as controls. Amount of HIV-1 p24 in the cell culture supernatants was determined by ELISA. Data are from one experiment representative of two independent experiments.
###end p 159
###begin title 160
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Is Internalized in B Cells
###end title 160
###begin p 161
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 162 167 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 313 318 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A-D) Transmission electron microscopy of HIV-1-loaded, activated B cells and DC. Activated B cells were left untreated (panel A) or loaded with AT-2-inactivated HIV-1 X4 (MN) for 1 h at 4 degreesC (panel B) or at 37 degreesC for 2 h (panel C). Immature DC (panel D) that were loaded with the same preparation of HIV-1 and incubated at 37 degreesC for 2 h were used as controls. Arrows indicate viral particles that have been internalized in cytoplasmic vesicles.
###end p 161
###begin p 162
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 156 161 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 173 178 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(E) HIV-1 p24 levels in post-trypsin treatment supernatants (sup) and cell pellets of activated B cells (lys) that had been incubated with AT-2-inactivated HIV-1 X4 (MN) or HIV-1 R5 (Ba-L) for 2 h at 37 degreesC, and then incubated with 0.25% trypsin solution for 10 min at 37 degreesC. Controls included activated B cells without virus, which were negative for p24 (unpublished data).
###end p 162
###begin p 163
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(F) Activated B cells were incubated with HIV-1 R5 (Ba-L) on wet ice, then washed and shifted at 37 degreesC for the times indicated. Cells were then treated with trypsin or mock treated and added to T cells. Supernatants were collected every 4 d and tested for p24. Data are from single experiments representative of three independent experiments.
###end p 163
###begin title 164
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Is Maintained in an Infectious Form by B Cells
###end title 164
###begin p 165
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 292 297 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activated B cells were loaded with HIV-1 X4 (IIIb) or HIV-1 R5 (Ba-L) for 2 h at 37 degreesC, extensively washed and then either cultured immediately with autologous T cells (panel A) or incubated for 2 d prior to adding autologous T cells (panel B). B cells and T cells directly loaded with HIV-1 served as controls.
###end p 165
###begin p 166
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Real-Time RT-PCR Measurement of DC-SIGN mRNA Levels in B cells of Seven Healthy, HIV-1 Seronegative Donors
###end p 166
###begin p 167
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. GR and CRR conceived and designed the experiments. GR, PP, CLF, and MJ performed the experiments. TAR, SCW, DTR, and PG contributed reagents/materials/analysis tools. GR and CRR analyzed the data and wrote the paper.
###end p 167
###begin p 168
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 168
###begin p 169
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This study was supported by the National Institutes of Health (R37AI041870, R01 CA082053 and U01 AI035041).
###end p 169

